Role of Pelvic Lymphadenectomy in Prostate Cancer Management

Urology

Volumn 69, Issue 2, 2007, Pages 203-209

  Sivalingam, S ^a   Oxley, J ^a   Probert, J L ^a   Stolzenburg, J U ^b   Schwaibold, H ^a  

^a SOUTHMEAD HOSPITAL   (United Kingdom)

^b UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

CANCER GROWTH; CANCER RELAPSE; CANCER STAGING; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; FALSE POSITIVE RESULT; GLEASON SCORE; HIGH RISK PATIENT; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT SELECTION; PELVIS LYMPHADENECTOMY; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROSTATECTOMY; REVIEW; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE; SURGICAL TECHNIQUE; SYMPTOMATOLOGY; SYSTEMATIC REVIEW;

AGED; BIOPSY, NEEDLE; DISEASE-FREE SURVIVAL; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROSTATECTOMY; PROSTATIC NEOPLASMS; RISK ASSESSMENT; SENTINEL LYMPH NODE BIOPSY; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 33847039236     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2006.10.031     Document Type: Review

References (50)

1. Heidi N., Petrelli N., Carlin A., et al. Guidelines 2000 for colon and rectal cancer surgery. J Natl Cancer Inst 93 (2001) 583-596
2. Benedet J.L., Bender H., Jones III H., et al., FIGO Committee on Gynecologic Oncology. Staging classification and clinical practice guidelines in the management of gynaecological cancers. Int J Gynaecal Obstet 70 (2000) 209-262
3. Bhatta-Dar N., Reuther A.M., Zippe C., et al. No difference in six-year biochemical failure rates with or without pelvic lymph-node dissection during radical prostatectomy in low risk patients with localised prostate cancer. Urology 63 (2004) 528-531
4. Salomon L., Hoznek A., Lefrère-Belda M.A., et al. Nondissection of pelvic lymph-node does not influence the results of perineal radical prostatectomy in selected patients. Eur Urol 37 (2000) 297-300
5. Bader P., Burkard F.C., Markwalder R., et al. Disease progression and survival of patients with positive after radical prostatectomy. Is there a chance for cure?. J Urol 169 (2003) 849-854
6. Frazier II H.A., Robertson J.E., and Paulson D.F. Does radical prostatectomy in the presence of positive pelvic lymph-node enhance survival?. World J Urol 12 (1994) 308-312
7. Han M., Partin A.W., Pound C.R., et al. Long-term biochemical disease free and cancer specific survival following anatomic radical retropubic prostatectomy: the 15 year Johns Hopkins experience. Urol Clin North Am 28 (2001) 555-565
8. Daneshmand S., Quek M.L., Stein J.P., et al. Prognosis of patients with lymph node positive prostate cancer following radical prostatectomy: long term results. J Urol 172 (2004) 2252-2255
9. Fowler J.E., and Whitmore Jr. W.F. The incidence and extent of pelvic lymph-node metastases in apparently localised prostate cancer. Cancer 47 (1981) 2941-2945
10. Partin A.W., Kattan M.W., Subong E.N., et al. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localised prostate cancer: a multi-institutional update. JAMA 147 (1997) 1445-1451
11. Partin A.W., Mongold L.A., Lamm D.M., et al. Contemporary update of prostate cancer staging nomograms (Partin tables) for the new millennium. Urology 58 (2001) 843-848
12. Cagiannos I., Karakiewicz P., Eastham J.A., et al. A pre-operative nomogram identifying decreased risk of positive pelvic lymph-nodes in patients with prostate cancer. J Urol 170 (2003) 1798-1803
13. Stefan C., Graefen M., Pichlmeier U., et al. Systematic sextant biopsies improve preoperative prediction of pelvic lymph node metastases in patients with clinically localised prostatic carcinoma. J Urol 159 (1998) 2023-2029
14. Conrad S., Graefen M., Pichlmeier U., et al. Prospective validation of an algorithm with systematic sextant biopsy to predict pelvic lymph node metastasis in patients with clinically localised prostatic carcinoma. J Urol 167 (2002) 521-525
15. Haese A., Epstein J.I., Hulland H., et al. Validation of biopsy based pathological algorithm for predicting lymph-node metastases in patients with clinically localised prostate carcinoma. Cancer 95 (2002) 1016-1021
16. Burkhard F.C., Bader P., Schneider E., et al. Reliability of pre-operative values to determine the need for lymphadenectomy in patients with prostate cancer and meticulous lymph-node dissection. Eur Urol 42 (2002) 84-92
17. Kondylis F.I., Moriarty R.P., Bostwick D., et al. Prostate cancer grade assignment: the effect of chronological, interpretive and translational bias. J Urol 170 (2003) 1189-1193
18. Gil-Vernet J.M. Prostate cancer: anatomical and surgical considerations. Br J Urol 78 (1996) 161-168
19. Schuessler W.W., Pharand D., and Vancaillie T.G. Laparoscopic standard pelvic node dissection for carcinoma of the prostate: is it accurate?. J Urol 150 (1993) 898-901
20. Bader P., Burkhard F.C., Markwalder R., et al. Is limited lymph-node dissection an adequate staging procedure for prostate cancer?. J Urol 168 (2002) 514-518
21. Heidenreich A., Varga Z., and Knobloch R.V. Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph-node metastasis. J Urol 167 (2002) 1681-1686
22. McDowell II G.C., Johnson J.W., Tenney D.M., et al. Pelvic lymphadenectomy for staging localised prostate cancer: indication, complication and results in 217 cases. Urology 35 (1990) 476-482
23. Wawroschek F., Hamm M., Weckermann D., et al. Lymph-node staging in clinically localised prostate cancer. Urol Int 71 (2003) 129-135
24. Clark T., Parekh D.J., Cookson M.S., et al. Randomised prospective evaluation of extended versus limited lymph-node dissection in patients with clinically localised prostate cancer. J Urol 169 (2003) 145-148
25. Weingärtner K., Ramaswamy A., Bittinger A., et al. Anatomical basis for pelvic lymphadenectomy in prostate cancer: results of an autopsy study and implications for the clinic. J Urol 156 (1996) 1969-1971
26. Herrell D.S., Trachtenberg J., and Theodorescu D. Staging pelvic lymphadenectomy for localised carcinoma of the prostate: a comparison of 3 surgical techniques. J Urol 157 (1997) 1337-1339
27. Allaf M.E., Palapattu G.S., Trock B.J., et al. Anatomical extent of lymph-node dissection: impact on men with clinically localised prostate cancer. J Urol 172 (2004) 1840-1844
28. Stone N.N., Stock R.G., and Unger P. Laparoscopic pelvic lymph-node dissection for prostate cancer: comparison of the extended and modified techniques. J Urol 158 (1997) 1891-1894
29. Parkin J., Keeley Jr. F.X., and Timoney A.G. Laparoscopic lymph-node sampling in locally advanced prostate cancer. BJU Int 89 (2002) 14-18
30. Shackley D.C., Irving S.O., Brough W.A., et al. Staging laparoscopic pelvic lymphadenectomy in prostate cancer. BJU Int 83 (1999) 260-264
31. Lezin S.M., Cherrie R., and Cattolica E.V. Comparison of laparoscopic and minilaparotomy pelvic lymphadenectomy for prostate cancer staging in a community practice. Urology 49 (1997) 60-64
32. Epstein J.I., Oesterling J.E., Eggleston J.C., et al. Frozen section detection of lymph-node metastases in prostatic carcinoma: accuracy in grossly uninvolved pelvic lymphadenectomy specimens. J Urol 136 (1986) 1234-1237
33. Young M.P.A., Kirby R.S., O'Donoghue E.P.N., et al. Accuracy and cost of intraoperative lymph-node frozen sections at radical prostatectomy. J Clin Pathol 52 (1999) 925-927
34. Beissner R.S., Stricker J.B., Speights V.O., et al. Frozen section diagnosis of metastatic prostate adenocarcinoma in pelvic lymphadenectomy compared with nomogram prediction of metastasis. Urology 59 (2002) 721-725
35. Winstanley A.M., Sandison A., Bott S.R.J., et al. Incidental findings in pelvic lymph-nodes at radical prostatectomy. J Clin Pathol 55 (2002) 623-626
36. Scott K.W., and Grace R.H. Detection of lymph-node metastases in colorectal carcinoma before and after fat clearance. Br J Surg 76 (1989) 1165-1167
37. Goldstein N.S. Lymph-node recoveries from 2427 pT3 colorectal resection specimens spanning 45 years: recommendations for a minimum number of recovered lymph-nodes based on predictive probabilities. Am J Surg Pathol 26 (2002) 179-189
38. Barth P.J., Gerharz E.W., Ramaswamy A., et al. The influence of lymph-node counts on the detection of pelvic lymph-node metastasis in prostate cancer. Pathol Res Pract 195 (1999) 633-636
39. Verrill C., Carr N.J., Wilkinson-Smith E., et al. Histopathological assessment of lymph-nodes in colorectal carcinoma: does triple levelling detect significantly more metastases?. J Clin Pathol 57 (2004) 1165-1167
40. Wawroschek F., Wagner T., Hamm M., et al. The influence of serial sections, immunohistochemistry and extension of pelvic lymph-node dissection on the lymph-node status in clinically localised prostate cancer. Eur Urol 43 (2003) 132-137
41. Rukstalis D.B., Gerber G.S., Vogelzang N.J., et al. Laparoscopic pelvic lymph-node dissection: a review of 103 consecutive cases. J Urol 151 (1994) 670-674
42. Solberg A., Angelsen A., Bergen U., et al. Frequency of lymphocoele after open and laparoscopic pelvic lymph-node dissection in patients with prostate cancer. Scan J Urol Nephrol 37 (2003) 218-221
43. Brenot-Rossi I., Bastide C., Garcia S., et al. Limited pelvic lymphadenectomy using the sentinel lymph-node procedure in patients with localised prostate carcinoma: a pilot study. Eur J Nucl Mol Imaging 32 (2005) 635-640
44. Gronau E., Weckermann D., and Harzmann R. Sentinel lymph node resection in prostate cancer patients with PSA higher than 20 ng/ml (abstract). J Urol 173 suppl 4 (2005) 437
45. Wolf Jr. J.S., Cher M., Dall'Era M., et al. Prostate cancer: the use and accuracy of cross sectional imaging and fine needle aspiration cytology for detection of pelvic lymph-node metastases before radical prostatectomy. J Urol 153 suppl 3S (1995) 993-999
46. Borley N., Fabrin K., Sriprasad S., et al. Laparoscopic pelvic lymph-node dissection allows significantly more accurate staging on "high risk" prostate cancer compared to MRI or CT. Scan J Urol Nephrol 37 (2003) 382-386
47. Ponsky L.E., Cherullo E.E., Starkey R., et al. Evaluation of pre-operative ProstaScint scans in the prediction of nodal disease. Prostate Cancer Prostatic Dis 5 (2002) 132-135
48. Schoder H., and Larson S.M. Positron emission tomography for prostate, bladder and renal cancer. Semin Nucl Med 34 (2004) 274-292
49. de Jong I.J., Pruim J., Elsinga P.H., et al. Pre-operative staging of pelvic lymph-node in prostate cancer by 11C-choline PET. J Nucl Med 44 (2003) 331-335
50. Harisinghani M.G., Barentsz J., Hahn P.F., et al. Nonivasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med 348 (2003) 2491-2499